Integra LifeSciences Holdings C - stock earnings
IART Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 19.8 million USD | 397.0 million USD |
| 2023Q3 | 19.5 million USD | 382.4 million USD |
| 2023Q2 | 4.2 million USD | 381.3 million USD |
| 2023Q1 | 24.2 million USD | 380.8 million USD |
| 2022Q4 | 52.9 million USD | 398.0 million USD |
| 2022Q3 | 49.9 million USD | 385.2 million USD |
| 2022Q2 | 44.8 million USD | 397.8 million USD |
| 2022Q1 | 32.9 million USD | 376.6 million USD |
| 2021Q4 | 45.4 million USD | 405.5 million USD |
| 2021Q3 | 43.2 million USD | 386.9 million USD |
| 2021Q2 | 35.1 million USD | 390.0 million USD |
| 2021Q1 | 45.4 million USD | 360.1 million USD |
| 2020Q4 | 92.7 million USD | 388.6 million USD |
| 2020Q3 | 32.3 million USD | 370.2 million USD |
| 2020Q2 | -369000 USD | 258.7 million USD |
| 2020Q1 | 9.2 million USD | 354.3 million USD |
| 2019Q4 | 15.3 million USD | 395.1 million USD |
| 2019Q3 | -27.6 million USD | 379.1 million USD |
| 2019Q2 | 29.7 million USD | 383.6 million USD |
| 2019Q1 | 32.8 million USD | 359.7 million USD |
| 2018Q4 | 25.1 million USD | 383.3 million USD |
| 2018Q3 | 13.3 million USD | 365.9 million USD |
| 2018Q2 | 11.4 million USD | 366.2 million USD |
| 2018Q1 | 11.0 million USD | 357.1 million USD |
| 2017Q4 | 44.4 million USD | 368.6 million USD |
| 2017Q3 | 3.2 million USD | 278.8 million USD |
| 2017Q2 | 10.8 million USD | 282.2 million USD |
| 2017Q1 | 6.4 million USD | 258.6 million USD |
| 2016Q4 | 28.2 million USD | 255.7 million USD |
| 2016Q3 | 20.1 million USD | 250.3 million USD |
| 2016Q2 | 12.8 million USD | 249.3 million USD |
| 2016Q1 | 11.6 million USD | 236.8 million USD |
| 2015Q4 | 15.0 million USD | 241.2 million USD |
| 2015Q3 | -31.9 million USD | 226.4 million USD |
| 2015Q2 | 5.0 million USD | 244.1 million USD |
| 2015Q1 | 8.4 million USD | 233.7 million USD |
| 2014Q4 | 17.2 million USD | 252.2 million USD |
| 2014Q3 | 9.8 million USD | 229.7 million USD |
| 2014Q2 | 4.8 million USD | 231.4 million USD |
| 2014Q1 | 2.2 million USD | 215.1 million USD |
| 2013Q4 | 12.2 million USD | 220.8 million USD |
| 2013Q3 | -28.6 million USD | 213.2 million USD |
| 2013Q2 | 3.4 million USD | 205.5 million USD |
| 2013Q1 | -4.1 million USD | 196.7 million USD |
| 2012Q4 | 12.8 million USD | 214.4 million USD |
| 2012Q3 | 13.2 million USD | 210.1 million USD |
| 2012Q2 | 8.5 million USD | 210.2 million USD |
| 2012Q1 | 6.7 million USD | 196.2 million USD |
| 2011Q4 | 4.6 million USD | 203.5 million USD |
| 2011Q3 | 11.2 million USD | 202.2 million USD |
| 2011Q2 | 699000 USD | 193.3 million USD |
| 2011Q1 | 11.5 million USD | 181.0 million USD |
| 2010Q4 | 18.8 million USD | 194.1 million USD |
| 2010Q3 | 16.5 million USD | 186.6 million USD |
| 2010Q2 | 15.2 million USD | 178.6 million USD |
| 2010Q1 | 15.2 million USD | 172.7 million USD |
| 2009Q4 | 15.7 million USD | 183.5 million USD |
| 2009Q3 | 14.4 million USD | 172.3 million USD |
| 2009Q2 | 11.2 million USD | 165.7 million USD |
| 2009Q1 | 9.6 million USD | 161.0 million USD |
| 2008Q4 | 24.8 million USD | 174.4 million USD |
| 2008Q3 | -15.3 million USD | 167.0 million USD |
| 2008Q2 | 13.8 million USD | 157.2 million USD |
| 2008Q1 | 5.4 million USD | 157.6 million USD |
| 2007Q4 | 5.4 million USD | 157.6 million USD |
| 2007Q3 | 9.7 million USD | 135.0 million USD |
| 2007Q2 | 9.3 million USD | 134.8 million USD |
| 2007Q1 | 9.1 million USD | 123.0 million USD |
| 2006Q4 | 10.1 million USD | 125.4 million USD |
| 2006Q3 | 2.6 million USD | 116.6 million USD |
| 2006Q2 | 8.0 million USD | 100.1 million USD |
| 2006Q1 | 8.7 million USD | 77.1 million USD |
| 2005Q4 | 10.6 million USD | 73.0 million USD |
| 2005Q3 | 10.5 million USD | 69.3 million USD |
| 2005Q2 | 7.7 million USD | 69.8 million USD |
| 2005Q1 | 8.4 million USD | 65.8 million USD |
| 2004Q4 | 9.8 million USD | 61.8 million USD |
| 2004Q3 | -7.6 million USD | 59.1 million USD |
| 2004Q2 | 7.5 million USD | 56.4 million USD |
| 2004Q1 | 7.4 million USD | 52.4 million USD |
| 2003Q4 | 9.2 million USD | 59.0 million USD |
| 2003Q3 | 6.8 million USD | 47.1 million USD |
| 2003Q2 | 5.4 million USD | 42.7 million USD |
| 2003Q1 | 5.4 million USD | 36.8 million USD |
| 2002Q4 | 25.4 million USD | 30.1 million USD |
| 2002Q3 | 1.6 million USD | 30.2 million USD |
| 2002Q2 | 4.2 million USD | 26.4 million USD |
| 2002Q1 | 4.1 million USD | 25.9 million USD |
| 2001Q4 | 17.6 million USD | 29.5 million USD |
| 2001Q3 | 3.8 million USD | 22.3 million USD |
| 2001Q2 | 2.8 million USD | 21.4 million USD |
| 2001Q1 | -12.2 million USD | 19.2 million USD |
| 2000Q4 | -12.2 million USD | 19.2 million USD |
| 2000Q3 | 1.7 million USD | 16.9 million USD |
| 2000Q2 | 84000 USD | 15.7 million USD |
| 2000Q1 | -1.1 million USD | 13.2 million USD |
| 1999Q4 | -800000 USD | 12.9 million USD |
| 1999Q3 | -2.0 million USD | 12.1 million USD |
| 1999Q2 | -3.6 million USD | 12.6 million USD |
| 1999Q1 | 400000 USD | 5.0 million USD |
| 1998Q4 | -2.9 million USD | 4.8 million USD |
| 1998Q3 | -2.9 million USD | 4.3 million USD |
| 1998Q2 | -3.2 million USD | 3.8 million USD |
| 1998Q1 | -3.3 million USD | 4.6 million USD |
| 1997Q4 | -10.7 million USD | 3.3 million USD |
| 1997Q3 | -2.5 million USD | 3.9 million USD |
| 1997Q2 | -2.0 million USD | 4.3 million USD |
| 1997Q1 | -1.8 million USD | 3.2 million USD |
| 1996Q4 | -2.3 million USD | 3.8 million USD |
| 1996Q3 | -2.1 million USD | 2.9 million USD |
| 1996Q2 | -1.5 million USD | 3.5 million USD |
| 1996Q1 | -1.6 million USD | 3.1 million USD |
| 1995Q4 | -2.2 million USD | 3.0 million USD |
| 1995Q3 | -21.0 million USD | 2.6 million USD |
| 1995Q2 | -1.1 million USD | 2.3 million USD |
| 1995Q1 | -1.1 million USD | 2.3 million USD |
IART Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 67.7 million USD | 1.5 billion USD |
| 2022 | 180.6 million USD | 1.6 billion USD |
| 2021 | 169.1 million USD | 1.5 billion USD |
| 2020 | 133.9 million USD | 1.4 billion USD |
| 2019 | 50.2 million USD | 1.5 billion USD |
| 2018 | 60.8 million USD | 1.5 billion USD |
| 2017 | 64.7 million USD | 1.2 billion USD |
| 2016 | 74.6 million USD | 992.1 million USD |
| 2015 | -3.5 million USD | 882.7 million USD |
| 2014 | 34.0 million USD | 928.3 million USD |
| 2013 | -17.0 million USD | 836.2 million USD |
| 2012 | 41.2 million USD | 830.9 million USD |
| 2011 | 28.0 million USD | 780.1 million USD |
| 2010 | 65.7 million USD | 732.1 million USD |
| 2009 | 51.0 million USD | 682.5 million USD |
| 2008 | 34.9 million USD | 654.6 million USD |
| 2007 | 33.5 million USD | 550.5 million USD |
| 2006 | 29.4 million USD | 419.3 million USD |
| 2005 | 37.2 million USD | 277.9 million USD |
| 2004 | 17.2 million USD | 229.8 million USD |
| 2003 | 26.9 million USD | 185.6 million USD |
| 2002 | 35.3 million USD | 112.6 million USD |
| 2001 | 26.2 million USD | 93.4 million USD |
| 2000 | -11.4 million USD | 65.0 million USD |
| 1999 | -6.0 million USD | 42.5 million USD |
| 1998 | -12.3 million USD | 17.5 million USD |
| 1997 | -17.0 million USD | 14.7 million USD |
| 1996 | -7.5 million USD | 13.1 million USD |
| 1995 | -25.4 million USD | 10.2 million USD |
IART
Price: $28.75
52 week price:
Earnings Per Share: 0.84 USD
P/E Ratio: 36.28
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 405021
Ebitda: 31.0 millionMarket Capitalization: 2.5 billion